Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis
Department
Allergy and Immunology
Document Type
Article
Publication Title
Allergy
First Page
2858
Last Page
2861
DOI
10.1111/all.16189
Volume
79
Issue
10
Publication Date
10-1-2024
Medical Subject Headings
Humans; Nasal Polyps (drug therapy, immunology, blood); Sinusitis (drug therapy, blood, immunology); Rhinitis (drug therapy, blood, immunology); Eosinophils (immunology); Immunoglobulin E (blood, immunology); Chronic Disease; Antibodies, Monoclonal, Humanized (therapeutic use); Treatment Outcome; Male; Female; Leukocyte Count; Middle Aged; Adult; Rhinosinusitis
PubMed ID
38850227
Recommended Citation
Bachert, C., Gevaert, P., Lipworth, B., Mustafa, S. S., Lane, A. P., Mullol, J., Rowe, P., Deniz, Y., Kamat, S., Khan, A. H., Jacob-Nara, J., Siddiqui, S., Ruddy, M., Laws, E., Msihid, J., Harel, S., Jagerschmidt, A., Amin, N., Mannent, L., & Rout, R. (2024). Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis. Allergy, 79 (10), 2858-2861. https://doi.org/10.1111/all.16189